PHIA Koninklijke Philips N.V.

Philips advances remote imaging leadership with FDA 510(k) clearance for innovative remote scanning and protocol management capabilities

Philips advances remote imaging leadership with FDA 510(k) clearance for innovative remote scanning and protocol management capabilities

November 22, 2024

  • Vendor-agnostic, multi-modality Radiology Operations Command Center (ROCC) connects technologists, radiologists, and operations teams in real time
  • New FDA 510(k) cleared remote scanning and protocol management help improve the operation of radiology workflows

Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major step forward in making radiology expertise for  diagnostic imaging accessible to more patients. The U.S. Food and Drug Administration (FDA) 510(k) clearance of remote scanning and remote protocol adjustment features on (ROCC) [1] means expert radiologists can now assist technologists on-the-spot, by remotely controlling scans or adjusting protocols to acquire high quality images needed for improved diagnostic confidence and patient outcomes.

“With the ROCC, innovation takes the lead in revolutionizing our daily radiology operations, enhancing our imaging capabilities, and providing staffing flexibility, enabling us to ultimately serve more patients more efficiently, overall delivering better patient care,” said Sherri Lewman, senior vice president of Enterprise Imaging at Tampa General Hospital [2].

ROCC is a multi-vendor, multi-modality, safe and secure imaging solution widely used in North America and Europe. It can be used with any vendor MR or CT configuration and seamlessly connects imaging experts in a command center with technologists at scan locations across their organization. A at Imperial College Healthcare NHS Trust in London, UK resulted in a 9% increase in total scanning throughput as a result of reduced scan times and a zero exam recall rate over the study period [3].

The remote scanning capabilities of ROCC [1] allow expert users to edit MR and CT scanner consoles in real time, from any location and share their expertise via on-demand chat, voice and video collaboration, without compromising privacy, safety or security. ROCC enables remote collaboration between imaging experts and on-site technologists to help with precise, first-time right image acquisition, for more efficient and enhanced patient care. 

“Healthcare providers are increasingly confronted with the challenge of not having enough skilled technologists to meet the demand for patient imaging exams, particularly for more complex exams such as cardiac MR,” said Shiv Gopalkrishnan, Business Leader Patient Care Informatics at Philips. “With the 510(k) clearance of ROCC’s remote scanning and remote protocol management capabilities [1] we are further empowering clinicians to deliver the timely diagnosis that patients deserve and helping to deliver better care for more patients.”

Philips will showcase ROCC in the Philips booth (#6730) at the Radiological Society of North America Annual Meeting, Dec. 1-4, 2024, in Chicago, USA. For more information, visit .

[1] Remote editing and protocol management are functions powered by the 510(k) cleared ROCC Console solution. Remote Image Acquisition is only to be used with a qualified user at the scanner.

[2]

[3] Based on results achieved in the ROCC Connectivity-Imperial NHS Trust Pilot Study. Increasing Imperial-NHS cardiac scanning capacity using ROCC for virtual training white paper. September 2024. Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions.

For further information, please contact:

Anna Hogrebe

Philips Global Press Office

Tel.:

E-mail:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring, and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,700 employees with sales and services in more than 100 countries. News about Philips can be found at .

Attachments



EN
22/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips and AWS expand strategic collaboration to advance HealthSuite ...

Philips and AWS expand strategic collaboration to advance HealthSuite cloud services and power generative AI workflows November 26, 2024 Cloud-enabled integrated diagnostics portfolio aims to unify workflows, improve access to critical insights, and drive better outcomes for patients Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its strategic collaboration with Amazon Web Services (AWS) to offer Philips’ integrated diagnostics portfolio in the cloud, including radiology, digital pathology, cardiology [1], and ...

 PRESS RELEASE

Philips and icometrix advance precision diagnosis in neurology with in...

Philips and icometrix advance precision diagnosis in neurology with innovative AI-based imaging solutions at #RSNA24 November 25, 2024icometrix’ FDA-cleared quantitative brain solution for neurological conditions including Alzheimer’s and multiple sclerosis is seamlessly integrated into Philips next generation BlueSeal MR scanners, and will be deployed in its comprehensive informatics platformAmsterdam, the Netherlands and Leuven, Belgium – (NYSE: PHG, AEX: PHIA), a global leader in health technology, and computer-aided diagnostics company (Leuven, Belgium) have teamed up to deploy an AI-...

 PRESS RELEASE

Philips advances remote imaging leadership with FDA 510(k) clearance f...

Philips advances remote imaging leadership with FDA 510(k) clearance for innovative remote scanning and protocol management capabilities November 22, 2024 Vendor-agnostic, multi-modality Radiology Operations Command Center (ROCC) connects technologists, radiologists, and operations teams in real timeNew FDA 510(k) cleared remote scanning and protocol management help improve the operation of radiology workflows Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major step forward in making radiology expertise for  diagnostic imagin...

 PRESS RELEASE

Philips unveils next-generation BlueSeal helium-free MRI system, integ...

Philips unveils next-generation BlueSeal helium-free MRI system, integrated with AI-enabled Smart Reading at #RSNA24 Nov. 21, 2024 Industry’s first wide bore, high-performance helium-free [1] 1.5T MR features AI assistance at every step in the MRI workflow, with seamless integration of cloud-based AI image reading and reporting tools on the MR scanner Philips BlueSeal helium-free magnet combined with compact and lightweight design allows flexibility of installations in difficult and remote locations to improve wider access to advanced MRIPhilips’ award-winning [2] AI-based SmartSpeed image...

 PRESS RELEASE

Philips Spectral CT 7500 RT, world’s first spectral 4DCT respiratory-g...

Philips Spectral CT 7500 RT, world’s first spectral 4DCT respiratory-gated imaging receives FDA 510(k) clearance November 12, 2024 Designed specifically for use in radiation oncology, new Spectral CT 7500 RT enables personalized radiation therapy planning to deliver better care for more cancer patients Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major advance in radiation oncology with 510(k) clearance from the US Food and Drug Administration (FDA) for its new detector-based spectral computed tomography (CT) radiotherapy s...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch